In recent news, Sanofi showcases an industrious activity in the biotech sector. miRecule, a startup, used its platform tech to secure a partnership with Sanofi. Meanwhile, the latter is planning a significant investment of $1.6 billion in Germany's biotech industry. Flu vaccine producers including CSL Seqirus, Sanofi, and GSK have commenced shipments for the coming flu season.
Novavax has struck a $1.2 billion deal with Sanofi, a move that has been defining for both entities. Sanofi has also delved into the Artificial Intelligence realm, partnering with OpenAI and Formation Bio to enhance drug development. Furthermore, Sanofi has initiated a global health unit to make a difference for patients in low and middle-income countries.
A notable highlight involves Sanofi making a $1.7 billion acquisition of Inhibrx. They have also committed to investments of €1 billion in French production sites. However, it is not all smooth sailing as Sanofi is facing a settlement of $100 million pertaining to Zantac cancer lawsuits.
Sanofi News Analytics from Fri, 01 Sep 2023 23:17:18 GMT to Sun, 14 Jul 2024 12:46:19 GMT - Rating 6 - Innovation 5 - Information 8 - Rumor -2
